Nature-Throid 1 GR — Class II drug recall D-0005-2021
Terminated recall by PD-Rx Pharmaceuticals, Inc., reported 2020-10-14, distributed in AZ, OK. CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the sam
| Recall number | D-0005-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, United States |
| Recall initiated | 2020-09-17 |
| Classified | 2020-10-02 |
| Reported by FDA | 2020-10-14 |
| Terminated | 2021-11-05 |
| Distributed | AZ, OK |
| Quantity | 20 bottles |
| Reason classes | potency, cgmp |
| NDC | 43063-0819-01 |
| Lot numbers | J18C68 |
| Expiration dates | 2020-10-31 |
Product
Nature-Throid 1 GR (65 mg), Each Tablet Contains: Thyroid USP 1 GR (65 mg), Liothyronine (T3) 9 mcg, Levothyroxine (T4) 38 mcg, 100 Tablets per bottle, Rx Only, Pkg By PD-Rx Pharmaceuticals Incorporated, Oklahoma City, OK 73127, NDC 43063-819-01.
Reason for recall
CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0005-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.